Serum leptin levels are associated with tamoxifen-induced hepatic steatosis

Current Medical Research and Opinion

Volumn 19, Issue 1, 2003, Pages 47-50

  Günel, Nazan ^a   Coşkun, Uǧur ^a   Toruner, Fusun Balos ^a   Sancak, Banu ^a   Yilmaz, Erdal ^a   Cengiz, Omer ^b   Elbeg, Sehri ^a   Uner, Aytug ^a   Ozkan, Secil ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Breast cancer; Hepatic steitosis; Leptins; Tamoxifen

Indexed keywords

LEPTIN; LIPID; TAMOXIFEN;

ADULT; AGED; ARTICLE; BODY WEIGHT; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FATTY LIVER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHOLESTEROL; FATTY LIVER; FEMALE; HUMANS; LEPTIN; LIVER FUNCTION TESTS; MIDDLE AGED; TAMOXIFEN; TRIGLYCERIDES;

EID: 0347296064     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125001308     Document Type: Article

References (25)

1. Leris C, Mokbel K. The prevention of breast cancer: an overview. Curr Med Res Opin 2001;16:252-7
2. Cai Q, Bensen M, Greene R, Kirchner J. Tamoxifen-induced transient multifocal hepatic fatty infiltration. Am J Gastroenterol 2000;95:277-9
3. Hoof MV, Horsmans Y. Tamoxifen-induced steatohepatitis. Ann Intern Med 1996;124:855
4. Pino HC, Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC. Tamoxifen-associated steatohepatitis - report of three cases. J Hepatol 1995;23:95-7
5. Pratt DS, Knox TA, Erban J. Tamoxifen-induced steatohepatitis. Ann Intern Med 1995;123:236
6. Coskun U, Toruner FB, Gunel N. Tamoxifen therapy and hepatic steatosis. Neoplasma 2002;49:61-4
7. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-5
9. Friedman JM. Leptin, leptin receptors, and the control of body weight. Nutrition 1997;56:38-46
10. Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998;115:997-1001
11. Less WR. Ultrasound of liver and spleen. In: Sutton D, ed. A Textbook of Radiology and Imaging. London: Churchill Livingstone, 1993:457-72
12. Morales M, Santana N, Soria A, Mosquera A, Ordovas J, Novoa J, Betancor P, Valeron PF, Diaz-Chico B, Chirino R. Effects of tamoxifen on serum lipid and apolipoprotein levels in post-menopausal patients with breast cancer. Breast Cancer Res Treat 1996;40:265-70
13. Love RR, Newcomb PA, Wiebe DA, Surawicz TS, Jordan VC, Carbone PP, DeMets DL. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node negative breast cancer. J Natl Cancer Inst 1990;82:1327-32
14. Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann Intern Med 1991;115:860-4
15. Thangaraju M, Kumar K, Gandhirajan R, Sachdanandam P. Effects of tamoxifen on plasma lipids and lipoprotein in post-menopausal women with breast cancer, Cancer 1994;73:659-63
16. Benshushan A, Brzezinski A. Tamoxifen effects on menopauseassociated risk factors and symptoms. Obstet Gynecol Survey 1999;54:272-8
17. Tanaka M, Nakaya S, Kumai T, Watanabe M, Tateishi T, Shimizu H, Kobayashi S. Effects of estrogen on serum leptin levels and leptin mRNA expression in adipose tissue in rats. Horm Res 2001;56:98-104
18. Marttunen MB, Andersson S, Hietanen P, Karonen S, Koistinen HA, Koivisto VA, Tiitinen A, Ylikorkala O. Antiestrogenic tamoxifen and toremifene increase serum leptin levels in post-menopausal breast cancer patients. Maturitas 2000;35:175-9
19. Murata Y, Ogawa Y, Saibara T, Nishioka A, Fujiwara Y, Fukumoto M, Inomata T, Enzan H, Onishi S, Yoshida S. Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. Oncol Rep 2000;7:1299-304
20. Nguyen MC, Stewart RB, Banerji MA, Gordon DH, Kral JG. Relationships between tamoxifen use, liver fat and body distribution in women with breast cancer. Int J Obes Relat Metab Disord 2001;25:296-8
21. Shelh SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45
22. Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepato-Gastroenterol 1999;46:2422-5
23. Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci S, Bagci S, Gulsen M, Karaeren N, Dagalp K. Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2000;95:3584-9
24. Mikhailidis DP, Ganotakis ES, Georgoulias VA, Vallance DT, Winder AF. Tamoxifen-induced hypertriglyceridaemia: seven case reports and suggestions for remedial action. Oncol Rep 1997;4:625-8
25. Elisaf MS, Nakou K, Liamis G, Pavlidis NA. Tamoxifen -induced severe hypertriglyceridemia and pancreatitis. Ann Oncol 2000;11:1067-9